Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobie J de Villiers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|May 25, 2023
Bone health and menopause: Osteoporosis prevention and treatmentTobie J de Villiers
Maturitas|July 23, 2013
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 studySantiago Palacios, Tobie J de Villiers, Fiorenzo De Cicco Nardone, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Fertility and Sterility|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Menopause (New York, N.Y.)|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Climacteric : the Journal of the International Menopause Society|February 18, 2012
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Menopause (New York, N.Y.)|June 23, 2009
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal womenDavid F Archer, JoAnn V Pinkerton, Wulf H Utian, et al.
Menopause (New York, N.Y.)|February 11, 2015
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fractureSantiago Palacios, Stuart L Silverman, Tobie J de Villiers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Endocrinology & Metabolism|May 25, 2023
Bone health and menopause: Osteoporosis prevention and treatmentTobie J de Villiers
Maturitas|July 23, 2013
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 studySantiago Palacios, Tobie J de Villiers, Fiorenzo De Cicco Nardone, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Fertility and Sterility|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Menopause (New York, N.Y.)|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Climacteric : the Journal of the International Menopause Society|February 18, 2012
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2012
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive agingSiobán D Harlow, Margery Gass, Janet E Hall, et al.
Menopause (New York, N.Y.)|June 23, 2009
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal womenDavid F Archer, JoAnn V Pinkerton, Wulf H Utian, et al.
Menopause (New York, N.Y.)|February 11, 2015
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fractureSantiago Palacios, Stuart L Silverman, Tobie J de Villiers, et al.
Pageof 1